Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Sanguineti

Showing results (171-180 of 199) with videos related to

Pageof 20
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 10, 2024
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiationGiuseppe Sanguineti, Maddalena Pavarini, Fernando Munoz, et al.
Scientific Reports|September 8, 2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt studyLaura Pizzuti, Paolo Marchetti, Clara Natoli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 7, 2022
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiationCesare Cozzarini, Michela Olivieri, Alessandro Magli, et al.
Medical Oncology (Northwood, London, England)|August 19, 2020
Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Daniela Alterio, Stefania Volpe, Almalina Bacigalupo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2024
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancerMaddalena Pavarini, Lisa Alborghetti, Stefania Aimonetto, et al.
Journal of Cellular Physiology|July 16, 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life settingTeresa Gamucci, Laura Pizzuti, Isabella Sperduti, et al.
Cancers|August 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos StudyEriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, et al.
Cancers|October 14, 2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective StudyEriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2026
Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized TrialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.
Biology Direct|June 23, 2025
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic reviewEriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
Pageof 20

Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 10, 2024
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiationGiuseppe Sanguineti, Maddalena Pavarini, Fernando Munoz, et al.
Scientific Reports|September 8, 2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt studyLaura Pizzuti, Paolo Marchetti, Clara Natoli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 7, 2022
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiationCesare Cozzarini, Michela Olivieri, Alessandro Magli, et al.
Medical Oncology (Northwood, London, England)|August 19, 2020
Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Daniela Alterio, Stefania Volpe, Almalina Bacigalupo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2024
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancerMaddalena Pavarini, Lisa Alborghetti, Stefania Aimonetto, et al.
Journal of Cellular Physiology|July 16, 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life settingTeresa Gamucci, Laura Pizzuti, Isabella Sperduti, et al.
Cancers|August 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos StudyEriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, et al.
Cancers|October 14, 2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective StudyEriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2026
Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized TrialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.
Biology Direct|June 23, 2025
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic reviewEriseld Krasniqi, Lorena Filomeno, Teresa Arcuri, et al.
Pageof 20